SCHEMBL28868020

SCHEMBL28868020

CC(C)(C)OC(=O)[N+]1(O)CCC1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.32
CTSK P43235 1/20 0.31
USP2 O75604 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5568399 0.93 HPGD (0.32) DGAT1CTSK
SCHEMBL569888 0.76 DGAT1 (0.31) DGAT1CTSK
SCHEMBL6320796 0.74 BTK (0.31) DGAT1
SCHEMBL14896297 0.73 DGAT1 (0.32) DGAT1CTSKUSP2SMN1; SMN2
SCHEMBL2064367 0.73 HPGD (0.33) DGAT1CTSKUSP2SMN1; SMN2
SCHEMBL7477261 0.72 CTSK (0.32) CTSK
SCHEMBL2785917 0.71 DGAT1 (0.31) DGAT1CTSK
SCHEMBL6608329 0.71 HPGD (0.32) DGAT1CTSK
SCHEMBL5421441 0.70 HPGD (0.31) DGAT1
SCHEMBL2434403 0.70 BTK (0.31) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104892582-B Azetidine as the mek inhibitor for treating proliferative disease 埃克塞利希斯股份有限公司 2019-09-27 CN disclosed
CN-109053523-A Azetidine as the mek inhibitor for treating proliferative disease 埃克塞利希斯股份有限公司 2018-12-21 CN disclosed